Issue 31, 2009

Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugs

Abstract

The first dichloroplatinum(II) conjugates of dicarba analogues of octreotide, which is expected to act as a ‘tumour-targeting device’, have been efficiently synthesized following a stepwise solid-phase approach; these compounds emulate the mechanism of cisplatin since they form a 1,2-intrastrand cross-link with two consecutive guanines of an oligonucleotide.

Graphical abstract: Solid-phase synthesis and DNA binding studies of dichloroplatinum(ii) conjugates of dicarba analogues of octreotide as new anticancer drugs

Supplementary files

Article information

Article type
Communication
Submitted
15 May 2009
Accepted
04 Jun 2009
First published
22 Jun 2009

Chem. Commun., 2009, 4705-4707

Solid-phase synthesis and DNA binding studies of dichloroplatinum(II) conjugates of dicarba analogues of octreotide as new anticancer drugs

F. Barragán, V. Moreno and V. Marchán, Chem. Commun., 2009, 4705 DOI: 10.1039/B909698A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements